(Q39278779)

10 September 2017

title

First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study (English)

1 reference

10 September 2017

0 references

F del Moral González

2

1 reference

10 September 2017

P Martínez del Prado

3

1 reference

10 September 2017

M. L. García de Paredes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

F. Del Moral González

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

P. Martínez Del Prado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

J. L. Martí Ciriquián

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

S. Enrech Francés

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

M. Cobo Dols

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

E. Esteban González

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

A. L. Ortega Granados

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

M. Majem Tarruella

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

J. D. Cumplido Burón

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

A. Gascó Hernández

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

E. López Miranda

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

J. P. Ciria Santos

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

F. J. de Castro Carpeño

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

28 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20926548

28 July 2024

publication date

6 October 2010

1 reference

full work available at URL

10 September 2017

https://academic.oup.com/annonc/article-pdf/22/4/924/569530/mdq449.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

http://annonc.oxfordjournals.org/cgi/content/abstract/22/4/924

28 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20926548

https://api.elsevier.com/content/article/PII:S0923753419385576?httpAccept=text/xml

28 July 2024

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ449

https://api.elsevier.com/content/article/PII:S0923753419385576?httpAccept=text/plain

28 July 2024

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ449

http://academic.oup.com/annonc/article-pdf/22/4/924/569530/mdq449.pdf

28 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ449

28 July 2024

1 reference

10 September 2017

volume

22

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

924-930

1 reference

Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Analysis and treatment of different types of neuropathic cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Neuropathic pain: a practical guide for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Epidemiology of refractory neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Pharmacologic management part 1: better-studied neuropathic pain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Pharmacologic management part 2: lesser-studied neuropathic pain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Cancer pain and analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Problems recruiting cancer patients to a comparative clinical trial of drug treatments for neuropathic pain in palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Contemporary assessment and management of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Assessment and treatment of neuropathic cancer pain following WHO guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Taxane-platinum combinations in advanced non-small cell lung cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Medical Oncology: IROX as second-line therapy for metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Translational medicine: cancer pain mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

The management of metastatic bone disease with the combination of bisphosphonates and radiotherapy: from theory to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Pain characteristics of advanced lung cancer patients referred to a palliative care service

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

Morphine and alternative opioids in cancer pain: the EAPC recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ449

[Epidemiological study of prevalence, incidence and neuropathic pain characterization in neurology units. PREVADOL study]

21 January 2018

16

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ449

Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer

28 July 2024

21

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ449

Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer

28 July 2024

23

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ449

28 July 2024

Identifiers

1 reference

10 September 2017

1 reference